International Conference on HIV and Drug Development Research - (ICHDDR-26)


3rd - 4th December, 2026 | Antalya, Turkey

Multi-format (In-person/Virtual)

Submit for Presentation Attendee Registration Conference Brochure
Registration Options →

Explore conference registration categories designed for every mode of participation.

Home About Organizer Call For Paper Paper Submission Author Guidelines Registration Presentation Guidelines Organizing Committee Collaboration Agenda Do's and Dont's Invitation Letter Venue Contact Us

Important Dates

Pre-registration Deadline

3rd November, 2026

Paper Submission Deadline

8th November, 2026

Last Date Of Registration

18th November, 2026

Date Of Conference

3rd - 4th December, 2026

Downloads

Conference Flyer
Sample Abstract
Sample Full Paper

Call for Papers

The (ICHDDR-26) is dedicated to advancing research excellence by bringing together leading scholars, scientists, and professionals from across the globe. It provides a platform for the dissemination of high-quality research and innovative methodologies.

With a strong focus on HIV, the conference promotes research that contributes to academic depth, practical insights, and interdisciplinary knowledge integration.

Authors are invited to submit papers addressing, but not limited to, the following areas:

  • Advancements in HIV drug development
  • Challenges in HIV vaccine research
  • Clinical trials for new HIV therapies
  • Patient perspectives on drug development
  • Global collaboration in drug research
  • Regulatory considerations in drug approval
  • Innovative drug delivery systems for HIV
  • Long-term effects of HIV medications
  • Access to new HIV treatments globally
  • Ethical considerations in drug research
  • Role of community in drug development
  • Evaluating effectiveness of HIV therapies
  • Drug resistance in HIV treatment
  • Future directions in HIV drug research
  • Impact of drug development on health outcomes
  • Training for researchers in drug development
  • Global health policies affecting drug access
  • Patient education on HIV medications
  • Collaboration between industry and academia
  • Monitoring and evaluation of drug efficacy

Peer Review Process

All submissions will be evaluated through a structured peer-review process to ensure academic rigor and contribution to the field. Accepted papers will be presented and may be considered for publication in high-quality journals and indexed conference proceedings.

Registration Details

Secure your participation by completing the registration process at the earliest. Limited presentation slots are allocated on a first-come, first-served basis.

Publication Opportunities

High-quality submissions will be prioritized for publication opportunities in recognized journals and indexed proceedings.

Submit Your Paper Today Register Early & Reserve Your Slot